<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>CARBINOXAMINE MALEATE- carbinoxamine maleateÂ tabletÂ </strong><br><strong>CARBINOXAMINE MALEATE- carbinoxamine maleateÂ syrupÂ </strong><br>Mikart, Inc.<br></p></div>
<h1><span class="Bold"></span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="ID_42fcb587-decf-48bc-9c18-05197308a4bf"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Carbinoxamine maleate is a histamine-H<span class="Sub">1</span> receptor blocking agent. </p>
<p>Each tablet contains 4 mg carbinoxamine maleate and the following inactive ingredients: anhydrous lactose, magnesium stearate, microcrystalline cellulose, and sodium starch glycolate.  </p>
<p>Each 5 mL (teaspoonful) of oral solution contains 4 mg carbinoxamine maleate and the following inactive ingredients: artificial bubble gum flavor, citric acid (anhydrous), glycerin, methylparaben, propylene glycol, propylparaben, purified water, sodium citrate (hydrous) and sorbitol solution.</p>
<p>Carbinoxamine maleate is freely soluble in water. Its structure is: </p>
<div class="Figure">
<a name="id22112274"></a><img alt="carbinoxamine maleate chemical structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=748c233b-6ab9-42d0-89ab-e7ead30f7947&amp;name=748c233b-6ab9-42d0-89ab-e7ead30f7947-01.jpg">
</div>
<p>2-[(4-chlorophenyl)-2-pyridinylmethoxy]-<span class="Italics">N</span>, N-<span class="Italics">dimethylethanamine</span> (Z)-2-butenedioate (1:1)</p>
<p>C<span class="Sub">16</span>H<span class="Sub">19</span>CIN<span class="Sub">2</span>OÂ·C<span class="Sub">4</span>H<span class="Sub">4</span>O<span class="Sub">4</span></p>
<p>MW= 406.86</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="ID_b039f64d-43a4-44f1-818e-841bf93197e7"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_5a6c97cc-8cfa-42ce-a123-25ab0a7c7411"></a><a name="section-2.1"></a><p></p>
<h2>Mechanism of Actions</h2>
<p class="First">Carbinoxamine maleate, an ethanolamine derivative, is an antihistamine with anticholinergic (drying) and sedative properties. Carbinoxamine appears to compete with histamine (type H1) for receptor sites on effector cells in the gastrointestinal tract, blood vessels and respiratory tract. </p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_6a0704ef-aec9-4ba9-9261-ce5f97c04770"></a><a name="section-2.2"></a><p></p>
<h2>Pharmacokinetics and Metabolism</h2>
<p class="First">Carbinoxamine is well absorbed from the GI tract and appears to be extensively metabolized by the liver, and excreted in the urine as inactive metabolites within 24 hours. Virtually no intact drug is extended in the urine. </p>
<p>In a study comparing a controlled-release suspension and a solution of carbinoxamine, healthy volunteers were administered a single dose of 8 mg carbinoxamine. A time to maximum concentration (Tmax) was between 1.5 hours to 5 hours, a peak plasma concentration (Cmax) of about 24 ng/mL was observed, and extent of exposure (AUC) was about 286 ng hr/mL. The serum half-life is reported to be 10 to 20 hours.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_248260aa-54ef-4d9b-8583-66c55e7e8bdc"></a><a name="section-2.3"></a><p></p>
<h2>Drug/Food Interactions</h2>
<p class="First">Carbinoxamine should not be used in patients with <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to carbinoxamine. Carbinoxamine may increase the effects of other drugs such as barbiturates, TCAs, MAO inhibitors such as Phenelzine (Nardil), Tranylcypromine (Parnate), or Selegiline (Eldepryl), alcohol, other antihistamines, and CNS depressants. Carbinoxamine can be taken with or without food.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_753809d3-b264-455c-bc4a-585413b94af7"></a><a name="section-2.4"></a><p></p>
<h2>Cardiovascular Effects</h2>
<p class="First">Cardiac effects, including prolongation of QT interval have not been adequately studied. Unlike other newer antihistamines, severe adverse cardiovascular effects are uncommon, and usually limited to over dosage situations.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_1079e30e-3988-4cde-8d9a-13826e4d6829"></a><a name="section-2.5"></a><p></p>
<h2>Special Populations</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_d575c4db-3465-4e00-9ac1-b06f676314e2"></a><a name="section-2.5.1"></a><p></p>
<h3>Pediatric Patients</h3>
<p class="First">Carbinoxamine should not be used in newborn or premature infants. Neonates have an increased susceptibility to anticholinergic side effects, such as CNS excitation, which may lead to <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_8790cf26-a6f2-42fc-9cc6-4a35ba14cf41"></a><a name="section-2.5.2"></a><p></p>
<h3>Pregnancy and Lactation</h3>
<p class="First">Safe use of carbinoxamine during pregnancy has not been established. Therefore, carbinoxamine should not be used in women who are, or may become pregnant. Carbinoxamine is in the FDA pregnancy Category C.</p>
<p>Women who are breast-feeding should avoid use of carbinoxamine, since small amounts appear to be distributed into breast milk. </p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_c3206897-36e3-47dc-919d-d9c293537631"></a><a name="section-2.5.3"></a><p></p>
<h3>Geriatric Patients</h3>
<p class="First">Carbinoxamine is more likely to cause <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, sedation, and <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> in elderly patients. The incidence of adverse reactions is higher in the elderly; therefore, a dosing adjustment may be necessary in this subpopulation.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="ID_69dd77b6-f9ed-461c-adb8-770b459dafa3"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Carbinoxamine maleate is effective for the symptomatic treatment of:</p>
<p>Seasonal and <span class="product-label-link" type="condition" conceptid="40486433" conceptname="Perennial allergic rhinitis">perennial allergic rhinitis</span>.</p>
<p><span class="product-label-link" type="condition" conceptid="4305500" conceptname="Vasomotor rhinitis">Vasomotor rhinitis</span>.</p>
<p><span class="product-label-link" type="condition" conceptid="374959" conceptname="Contact blepharoconjunctivitis">Allergic conjunctivitis</span> due to inhalant allergens and foods.</p>
<p>Mild, uncomplicated allergic skin manifestations of <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> and <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span>. </p>
<p>Dermatographism.</p>
<p>As therapy for <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reactions</span> <span class="Italics">adjunctive</span> to epinephrine and other standard measures after the acute manifestations have been controlled. </p>
<p>Amelioration of the severity of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> to blood or plasma. </p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="ID_e5b5a34a-b816-4f88-a9e7-fa19995e50b9"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Carbinoxamine maleate is contraindicated in children younger than 2 years of age. </p>
<p>Carbinoxamine maleate is contraindicated in nursing mothers.</p>
<p>Carbinoxamine maleate is contraindicated in patients who are hypersensitive to the drug or on monoamine oxidase inhibitor therapy. (See <a href="#ID_e1016d54-4335-4498-b1c8-d2cb75d39260">Drug Interactions</a> section).</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="ID_b22571b4-5edb-4d24-b4fe-47cecb483ea9"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">Deaths</span> have been reported in children less than 2 years of age who were taking antihistamines, including carbinoxamine-containing drug products, therefore, carbinoxamine maleate is contraindicated in children younger than 2 years of age (see <a href="#ID_e5b5a34a-b816-4f88-a9e7-fa19995e50b9">CONTRAINDICATIONS</a>).</p>
<p>Antihistamines should be used with considerable caution in patients with: narrow angle <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, stenosing <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span>, symptomatic <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>, <span class="product-label-link" type="condition" conceptid="433813" conceptname="Bladder neck obstruction">bladder neck obstruction</span>, pyloroduodenal obstruction.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="ID_faa8b55f-8553-474e-87c5-767d650c8717"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="ID_1fca19dc-310a-42c1-b5f3-d3054138f9b2"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">As many other antihistamines, carbinoxamine maleate has an atropine-like action and, therefore, should be used with caution in patients with: <span class="product-label-link" type="condition" conceptid="4011560" conceptname="Raised intraocular pressure">increased intraocular pressure</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, cardiovascular disease, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>. </p>
<p>Antihistamines such as carbinoxamine maleate should be not be used to treat lower respiratory tract symptoms, including <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>. </p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="ID_3d5a8fc7-486c-4a67-9269-d1fb151acb08"></a><a name="section-6.2"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">Carbinoxamine maleate may cause <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>; alcohol, sedatives, and tranquilizers may increase the <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> effect. Avoid alcoholic beverages while taking this product. Do not take this product if you are taking sedatives or tranquilizers, without first consulting your doctor. Use caution when driving a motor vehicle or operating machinery. </p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="ID_e1016d54-4335-4498-b1c8-d2cb75d39260"></a><a name="section-6.3"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Monoamine oxidase inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines.</p>
<p>Carbinoxamine maleate has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc.). </p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="ID_79ad3c51-0e5e-474d-abd9-31a10d35b300"></a><a name="section-6.4"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">No long-term studies in animals have been performed to determine the possible effects of carbinoxamine maleate on carcinogenesis, mutagenesis, and fertility. </p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="ID_c23f3f94-ae01-4f9a-b6b5-117bc54f4cee"></a><a name="section-6.5"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_73fdb3a9-319d-4431-8cd4-4c3cda965397"></a><a name="section-6.5.1"></a><p></p>
<h3>Pregnancy Category C</h3>
<p class="First">Animal reproductive studies have not been conducted with carbinoxamine maleate. It is also not known whether carbinoxamine maleate can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Carbinoxamine maleate should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="ID_7d7124f3-9464-41ee-82ee-7dd70ee4d976"></a><a name="section-6.6"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">Because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, use of carbinoxamine maleate is contraindicated in nursing mothers (see <a href="#ID_e5b5a34a-b816-4f88-a9e7-fa19995e50b9">CONTRAINDICATIONS</a> section).</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="ID_ed4ac7e0-a81d-4e2f-8b98-02d1e51067fa"></a><a name="section-6.7"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Carbinoxamine maleate is contraindicated in children younger than 2 years of age (see <a href="#ID_e5b5a34a-b816-4f88-a9e7-fa19995e50b9">CONTRAINDICATIONS</a>). </p>
<p>Neonates have an increased susceptibility to anticholinergic side effects, such as CNS excitation, which may lead to <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>.</p>
<p>Carbinoxamine maleate may diminish mental alertness in children. In the young child, particularly, they may produce excitation. </p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="ID_c7649f15-be8f-4a9c-9b3e-d16802e5def5"></a><a name="section-6.8"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Carbinoxamine maleate is more likely to cause <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, sedation, and <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> in elderly patients (approximately 60 years or older). Sedating drugs may also cause <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span> and over sedation in the elderly. Therefore, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic renal, or cardiac function, and of concomitant disease or other drug therapy. </p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="ID_4d9c74ec-ce1d-4b35-93d1-e0cfe65ec981"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">The most frequent adverse reactions are underlined:</p>
<p><span class="Italics">Body as a Whole:</span> <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">Urticaria</span>, <span class="product-label-link" type="condition" conceptid="4080559" conceptname="Baboon syndrome">drug rash</span>, <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic shock</span>, <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">photosensitivity</span>, excessive perspiration, <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span>, dryness of mouth, nose and throat.</p>
<p><span class="Italics">Cardiovascular:</span> <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">Hypotension</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitations</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="316429" conceptname="Premature beats">extrasystoles</span>.</p>
<p><span class="Italics">Hematologic</span>: <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">Hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>.</p>
<p><span class="Italics">Central Nervous System:</span><span class="Underline">Sedation</span>, <span class="Underline"><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">sleepiness</span></span>, <span class="Underline"><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span></span>, <span class="Underline">disturbed coordination</span>, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, excitation, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="4142453" conceptname="Feeling high">euphoria</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesia</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, <span class="product-label-link" type="condition" conceptid="373474" conceptname="Diplopia">diplopia</span>, <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span>, <span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">tinnitus</span>, acute <span class="product-label-link" type="condition" conceptid="74052" conceptname="Labyrinthitis">labyrinthitis</span>, <span class="product-label-link" type="condition" conceptid="434889" conceptname="Dissociative disorder">hysteria</span>, <span class="product-label-link" type="condition" conceptid="444252" conceptname="Neuritis">neuritis</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>.</p>
<p><span class="Italics">Gastrointestinal:</span><span class="Underline">Epigastric</span><span class="Underline"> distress</span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>.</p>
<p><span class="Italics">Urogenital</span><span class="Italics">:</span> <span class="product-label-link" type="condition" conceptid="4012368" conceptname="Increased frequency of urination">Urinary frequency</span>, difficult urination, <span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">urinary retention</span>, early menses.</p>
<p><span class="Italics">Respiratory:</span><span class="Underline">Thickening of bronchial secretions</span>, tightness of chest and <span class="product-label-link" type="condition" conceptid="314754" conceptname="Wheezing">wheezing</span>, <span class="product-label-link" type="condition" conceptid="4195085" conceptname="Nasal congestion">nasal stuffiness</span>.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="ID_2fe2e648-d045-4f52-a201-07088294e3c4"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_29637cc3-2703-477a-9c64-f724a2c9a339"></a><a name="section-8.1"></a><p></p>
<h2>Manifestations</h2>
<p class="First">Antihistamine overdosage reactions may vary from central nervous system <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> to stimulation. Stimulation is particularly likely in children. Atropine-like signs and symptoms- <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>; fixed, <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">dilated pupils</span>; <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>; and <span class="product-label-link" type="condition" conceptid="4302537" conceptname="Digestive system finding">gastrointestinal symptoms</span> may also occur. </p>
<p>Especially in infants and children, antihistamine overdosage may cause <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.</p>
<p>The oral LD<span class="Sub">50</span> of carbinoxamine maleate in guinea pigs is 411 mg/kg. </p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_25444f04-534b-453f-922a-a7e4e4304360"></a><a name="section-8.2"></a><p></p>
<h2>Treatment</h2>
<p class="First">The treatment of overdosage with carbinoxamine maleate is essentially symptomatic and supportive. Vital signs (including respiration, pulse, blood pressure, and temperature) and EKG should be monitored. Induction of <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> is not recommended. Activated charcoal should be given and gastric lavage should be considered after ingestion of a potentially life-threatening amount of drug. In the presence of severe anticholinergic effects, physostigmine may be useful. Vasopressors may be used to treat <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>. </p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="ID_d121dd2f-2e67-48bd-a75f-24ddc43c55ed"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Carbinoxamine maleate is contraindicated in children younger than 2 years of age (see <a href="#ID_e5b5a34a-b816-4f88-a9e7-fa19995e50b9">CONTRAINDICATIONS</a>).</p>
<p>Carbinoxamine maleate should be taken on an empty stomach with water. </p>
<p>DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT.</p>
<p>Carbinoxamine maleate dosage should be based on the severity of the condition and the response of the patient. The drug is well tolerated in adults in doses as high as 24 mg daily, in divided doses, over <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span>. On the other hand, some patients respond to as little as 4 mg daily. </p>
<p>Clinical experience suggests the following dosage schedules:</p>
<p><span class="Bold"><span class="Italics">Tablets</span></span></p>
<p>Usual Adult Dosage: 1 or 2 tablets (4 to 8 mg) 3 to 4 times daily</p>
<p>Usual Childâ€™s Dosage: Six to eleven years â€“ Â½ to 1 tablet (2 to 4 mg) 3 to 4 times daily</p>
<p><span class="Bold"><span class="Italics">Oral Solution</span></span></p>
<p>Usual Adult Dosage: 1 or 2 teaspoonfuls (4 to 8 mg) 3 to 4 times daily</p>
<p>Usual Childâ€™s Dosage (approximately 0.2 to 0.4 mg/kg/day, divided into 3 to 4 doses);</p>
<p>Six to eleven years â€“ Â½ to 1 teaspoonful (2 to 4 mg) 3 to 4 times daily.</p>
<p>Dosing for children 2 to 5 years of age should be based on weight whenever possible. The usual dosage for children 2 to 5 years of age is approximately 0.2 to 0.4 mg/kg/day, divided into 3 to 4 daily doses. In general, this corresponds to a dose of Â¼ to Â½ teaspoonful (1 to 2 mg) 3 to 4 times daily.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="ID_c16e6482-965d-4030-985d-83594f85e381"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Carbinoxamine Maleate Tablets, USP 4 mg are supplied as white, round, scored tablets, debossed â€œPALâ€? on one side and score â€œ4â€? on the other side, and are supplied in bottles of 100 tablets, NDC 46672-191-10 and bottles of 500 tablets, NDC 46672-191-50.</p>
<p>Carbinoxamine Maleate Oral Solution, 4 mg/5 mL is supplied as clear, colorless liquid with a bubble gum aroma, and is supplied in 4 oz bottles NDC 46672-644-04 and 16 oz bottles NDC 46672-644-16.</p>
<p>Store at controlled room temperature, 15Â°C to 30Â°C (59Â°F to 86Â°F) [See USP].</p>
<p>Dispense in a tight, light-resistant container with a child-resistant closure as defined in the official compendium. </p>
<p><span class="Bold">Manufactured by:</span></p>
<p>MIKART, INC.</p>
<p>Atlanta, GA 30318</p>
<p>Code 838A00</p>
<p>Rev. 06/07</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_f7bc4a06-2cce-4ab7-8586-0fe0077e8726"></a><a name="section-11"></a><p></p>
<h1>Package/Label Display Panel</h1>
<div class="Figure">
<a name="id14853211"></a><img alt="4 mg tablets container label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=748c233b-6ab9-42d0-89ab-e7ead30f7947&amp;name=748c233b-6ab9-42d0-89ab-e7ead30f7947-02.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_5810b672-3f7c-4631-8454-db886107ccfb"></a><a name="section-12"></a><p></p>
<h1>Package/Label Display Panel</h1>
<div class="Figure">
<a name="id14853229"></a><img alt="4 mg/5 mL oral solution container label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=748c233b-6ab9-42d0-89ab-e7ead30f7947&amp;name=748c233b-6ab9-42d0-89ab-e7ead30f7947-03.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>CARBINOXAMINE MALEATEÂ 		
					</strong><br><span class="contentTableReg">carbinoxamine maleate tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:46672-191</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>CARBINOXAMINE MALEATE</strong> (CARBINOXAMINE) </td>
<td class="formItem">CARBINOXAMINE MALEATE</td>
<td class="formItem">4Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ANHYDROUS LACTOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM STARCH GLYCOLATE TYPE A POTATO</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">7mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">PAL;4</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:46672-191-10</td>
<td class="formItem">100  in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:46672-191-50</td>
<td class="formItem">500  in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA040442</td>
<td class="formItem">03/19/2003</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>CARBINOXAMINE MALEATEÂ 		
					</strong><br><span class="contentTableReg">carbinoxamine maleate syrup</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:46672-644</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>CARBINOXAMINE MALEATE</strong> (CARBINOXAMINE) </td>
<td class="formItem">CARBINOXAMINE MALEATE</td>
<td class="formItem">4Â mg Â inÂ 5Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ANHYDROUS CITRIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>GLYCERIN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>METHYLPARABEN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PROPYLENE GLYCOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>PROPYLPARABEN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM CITRATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SORBITOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">Â Â Â Â </td>
<td class="formLabel">Score</td>
<td class="formItem">Â Â Â Â </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">BUBBLE GUM</td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:46672-644-04</td>
<td class="formItem">118 mL in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:46672-644-16</td>
<td class="formItem">473 mL in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA040458</td>
<td class="formItem">04/25/2003</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Mikart, Inc.
							(030034847)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 8/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>748c233b-6ab9-42d0-89ab-e7ead30f7947</div>
<div>Set id: 748c233b-6ab9-42d0-89ab-e7ead30f7947</div>
<div>Version: 1</div>
<div>Effective Time: 20150810</div>
</div>
</div>Â <div class="DistributorName">Mikart, Inc.</div></p>
</body></html>
